Compugen Ltd. (NASDAQ: CGEN) is One of Tuesday Morning’s Most Active StocksCompugen Ltd. (
NASDAQ: CGEN) is one today’s most active stocks by volume. So far today, approximately 61,549 shares of Compugen Ltd. have been exchanged, as compared to an average 30-day volume of 128.42k shares.
Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program
Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, headquartered in Holon, Israel, to exclusively license its potential first-in-class, pre-clinical antibody program against IL-18 binding protein, including the COM503 drug candidate.
Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONNIn the past week, there has been a strong surge in interest in biotech stocks and that is a trend that investors ought to look into. Considering the fact that it is a highly innovative sector, it may well be a good move to keep an eye on. There have been certain biotech stocks that have managed to record massive gains in the past week and here is a look at four of those.
